ADIENNE Pharma & Biotech

ADIENNE Pharma & Biotech is deeply committed to the vital work of pharmacovigilance, believing in the necessity of rigorous benefit-risk profile monitoring for all medicinal products. We’re honored to bring our scientific insights to the European Pharmacovigilance Congress, helping drive forward key discussions on advancing patient safety.

ADIENNE is pleased to announce its presence at SIFO congress from 17 to 20 October 2024 in Naples (Italy) ADIENNE is presenting its worlwide unique patented technologies for Ready-to-Infuse presentation, named Single and Multi-chamber flexible bags Designed to be activated at time of use, ADIENNE’s Multi Chamber Flexible Bags pursue and inspire a new frontier of administration in oncology. Integrated into a single flexible container, a cytotoxic drug as lyophilized powder or concentrated solution, can be aseptically reconstituted by its specific solvents apportioned in the same bag through a fast, accurate, needle free activation, to be diluted and directly administered. Device and Process have been specifically developed to directly carry out the lyophilization of water unstable drugs, to aseptically fill and host alcoholic solvent and diluents, to accurately reconstitute and administer the combination product at once, in the same flexible primary container. This innovative combination products generation avoids drug manipulation, contamination, eliminates possible spillages and aerosol during the reconstitution and dose adjustment practices, protecting medical personnel by the risks of exposure to high potent or cytotoxic drugs. The flatness of the active chambers design allows to neutralize the negative impact of head space effect of standard primary packaging container for poor stable lyophilized products. SHELF LIFE and IN USE STABILITY are extended.The technology applied also aims to preserve and maximize the stability of poorly stable drugs up to the moment of use, simplifying the complexity of the traditional reconstitution and dose adjustment practices, minimizing the number of steps, significantly reducing the lead time between preparation and infusion of large volume parenteral drugs to patients.

ADIENNE Pharma&Biotech al Congresso "Il futuro delle UFA..." presso l'Università Humanitas di Milano** Siamo entusiasti di annunciare la partecipazione di ADIENNE al prestigioso congresso "Il futuro delle UFA..." tenutosi presso l'Università Humanitas di Milano. Questo evento riunisce professionisti del settore sanitario impegnati nel migliorare i percorsi terapeutici per i pazienti oncologici, con un focus specifico sulle sfide nell'allestimento dei farmaci citotossici. ADIENNE è in prima linea nella trasformazione dei sistemi tradizionali di ricostituzione dei farmaci citotossici, passando dai sistemi basati su fiale ai più avanzati e sicuri sistemi di sacche multi-camera (MCB) pronte all’uso. Questa transizione è favorita dall'integrazione di tecnologie innovative e dalla crescente necessità di processi di preparazione del farmaco più efficienti e sicuri nel trattamento di malattie che richiedono l'uso di farmaci citotossici. ADIENNE e’ l’unica azienda al mondo che produce e commercializza farmaci citotossici in formulazioni pronte all’uso. Per saperne di più: https://www.adienne.com #Oncologia #InnovazioneSanitaria #CuraDelPaziente #Sicurezza #sistemireadytouse

ADIENNE is very pleased and proud to announce that, on 21st February 2023, received the AIFA Authorization for New production line called Fill-Choice. Fill-Choice is a new patented Ready To Use solution for chemotherapy. It is a single device containing the freeze-dried product in a vial and the related solvent in a sterile bag. Fill-Choice has been designed for avoiding any possible contamination for the product and for the personnel by ensuring the sterility and the containment of the powder. Freez dried reconstitution step doesn’t require needles or other tools that could affect the sterility of the process, allowing the immediately infusion to the patient. This is the third line authorization received form AIFA in addition to the two lines already granted for Multichambers Flexible Bag Ready To Use and vials. This Authorization for the New Production line Fill-Choice will allow ADIENNE to start production activities of commercial batches of Cytotoxic and Cytostatic Products different configurations and devices, that are fully dedicated to the health of patients and the safety of operators in the Hospitals. Thanks to this new Authotization, ADIENNE continues to consolidate its presence in the pharmaceutical field as worldwide leader manufacturer of Ready To Use systems for pharma&biotech products.